Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica, Accelrys, SciTegic, Locus Pharmaceuticals, GeneGo

Premium

Eli Lilly Licenses Inpharmatica's Admensa Interactive

Inpharmatica said this week that Eli Lilly has licensed its Admensa Interactive suite of predictive ADME models and compound-prioritization tools.

"We are delighted that Lilly, with its significant in-house strength in computational ADME, has chosen AI to augment its discovery support," said John Lisle, CEO of Inpharmatica.

Financial terms of the agreement were not disclosed.


Jazz Pharmaceuticals Uses SciTegic's Pipeline Pilot for Sales Support

Accelrys said this week that Jazz Pharmaceuticals has licensed the Pipeline Pilot workflow software from its SciTegic division to support a "full-featured sales force automation tool and a robust sales reporting architecture."

Jazz Pharmaceuticals will use Pipeline Pilot to support a web-based contact management system and will also use the platform to integrate applications that process clinical and other life sciences data.

Mathew Hahn, chief science and technology officer at Accelrys, said in a statement that the agreement "validates the advantages of our platform, which can be applied to both scientific and non-scientific applications."


Locus Pharmaceuticals Partners with Ono Pharmaceutical on Computational Drug Design

Locus Pharmaceuticals has entered into a research agreement with Ono Pharmaceutical in which it will use its computational drug-design capabilities to develop preclinical drug candidates for a protein kinase selected by Ono.

Financial and other terms of the multi-year agreement were not disclosed.


Siena Biotech Extends MetaCore License

GeneGo said this week that Siena Biotech has expanded its license to its MetaCore informatics platform.

Siena is using MetaCore to integrate multiple data types including proteomics and chemogenomics information.

Financial terms were not disclosed.

Filed under

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.